Central monoamine metabolism in depressions. II. Catecholamines and related compounds.
D001921:Brain / Q000378:metabolism; D003863:Depression / Q000188:drug therapy / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D013006:Growth Hormone / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007099:Imipramine / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D007986:Luteinizing Hormone / Q000097:blood; D008734:Methoxyhydroxyphenylglycol / Q000378:metabolism; D009627:Nomifensine / Q000627:therapeutic use; D009638:Norepinephrine / Q000378:metabolism*; D009661:Nortriptyline / Q000627:therapeutic use; D010300:Parkinson Disease / Q000378:metabolism; D010891:Piribedil / Q000627:therapeutic use; D011388:Prolactin / Q000097:blood; D014443:Tyrosine / Q000627:therapeutic use; D014642:Vanilmandelic Acid / Q000378:metabolism
D009627:Nomifensine; D014443:Tyrosine; D007980:Levodopa; D008734:Methoxyhydroxyphenylglycol; D014642:Vanilmandelic Acid; D011388:Prolactin; D007986:Luteinizing Hormone; D013006:Growth Hormone; D009661:Nortriptyline; D010891:Piribedil; D007099:Imipramine; D004298:Dopamine; D006854:Hydrocortisone; D009638:Norepinephrine; D006719:Homovanillic Acid